These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 29436672)
1. Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells. Keeratichamroen S; Lirdprapamongkol K; Svasti J Oncol Rep; 2018 Apr; 39(4):1765-1774. PubMed ID: 29436672 [TBL] [Abstract][Full Text] [Related]
2. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways. Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779 [TBL] [Abstract][Full Text] [Related]
4. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells. Aldonza MB; Hong JY; Bae SY; Song J; Kim WK; Oh J; Shin Y; Lee SH; Lee SK PLoS One; 2015; 10(6):e0127841. PubMed ID: 26098947 [TBL] [Abstract][Full Text] [Related]
5. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform. Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510 [TBL] [Abstract][Full Text] [Related]
6. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line. Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432 [TBL] [Abstract][Full Text] [Related]
7. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells. Hu CF; Huang YY; Wang YJ; Gao FG Oncol Rep; 2016 Jul; 36(1):455-61. PubMed ID: 27221310 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells. Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431 [TBL] [Abstract][Full Text] [Related]
10. Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells. Xu M; Tang X; Guo J; Sun W; Tang F Oncol Rep; 2017 Nov; 38(5):2843-2851. PubMed ID: 29048638 [TBL] [Abstract][Full Text] [Related]
11. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357 [TBL] [Abstract][Full Text] [Related]
12. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells. Akizuki R; Maruhashi R; Eguchi H; Kitabatake K; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):769-780. PubMed ID: 29524521 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Ni L; Feng Y; Wan H; Ma Q; Fan L; Qian Y; Li Q; Xiang Y; Gao B Oncol Rep; 2012 Mar; 27(3):783-90. PubMed ID: 22089256 [TBL] [Abstract][Full Text] [Related]
14. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes. Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258 [TBL] [Abstract][Full Text] [Related]
15. Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways. Li G; He Y; Yao J; Huang C; Song X; Deng Y; Xie S; Ren J; Jin M; Liu H Oncol Rep; 2016 Dec; 36(6):3504-3512. PubMed ID: 27748898 [TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 regulates cell apoptosis and invasion ability in paclitaxel-induced multidrug-resistant A549 lung cancer cells. Han F; Zhang L; Zhou Y; Yi X Int J Clin Exp Pathol; 2015; 8(8):8937-47. PubMed ID: 26464635 [TBL] [Abstract][Full Text] [Related]
17. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010 [TBL] [Abstract][Full Text] [Related]
18. Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism. Zhong GX; Gong Y; Yu CJ; Wu SF; Ma QP; Wang Y; Ren J; Zhang XC; Yang WH; Zhu W Tumour Biol; 2015 Jun; 36(6):4689-97. PubMed ID: 25619477 [TBL] [Abstract][Full Text] [Related]
19. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
20. Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469 [No Abstract] [Full Text] [Related] [Next] [New Search]